510(k) Report

510(k) · Cleared

Recalled · Class II · 2017

Vistakon (Galyfilcon a) Soft Contact Lens

K032340510(k) TraditionalCleared Oct 16, 200379-day reviewClass II21 CFR 886.5925Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Johnson & Johnson Vision Care, Inc. · LPL Lenses, Soft Contact, Daily Wear

Cleared on Oct 16, 2003 after a 79-day review. The FDA summary names its predicate without a number. 33 later devices descend from it. It has been recalled once.

Decided
Oct 16, 2003
Review
79 days
Class
Class II
Product code
LPL
Recalls
1
Predicates
0

33 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2008: 1 descendant cleared2013: 2 descendants cleared2010: 1 descendant cleared2014: 2 descendants cleared2016: 1 descendant cleared2025: 3 descendants cleared2012: 1 descendant cleared2018: 8 descendants cleared2020: 5 descendants cleared2019: 2 descendants cleared2023: 3 descendants cleared2026: 2 descendants cleared2024: 2 descendants cleared200020052010201520202025
  1. This deviceK032340 Vistakon (Galyfilcon a) Soft Contact LensJohnson & Johnson Vision Care, Inc. · 2003
  2. Descendant · cites it directly · 30 of its ownK073485 Vistakon (Narafilcon) a Soft Contact LensJohnson & Johnson Vision Care, Inc. · 2008
  3. Descendant · 2 generations on · 13 of its ownK100349 Vistakon (Narafilcon B) Contact Lens Visibility Tinted with UV BlockerJohnson & Johnson Vision Care, Inc. · 2010
  4. Descendant · 3 generations on · 12 of its ownK113168 Dailies Total Dalies Total for Astigmatism Dailies Total Multifocal…Ciba Vision Corporation · 2012
  5. Descendant · 2 generations on · 8 of its ownK160344 Si-Hy (olifilcon B) sperical silicone hydrogel soft contact lens…Visco Vision, Inc. · 2016
  6. Descendant · 2 generations on · 6 of its ownK130331 Sauflon Clariti 1 Day (Somofilcon a) Soft (Hydrophilic) Daily…Sauflon Pharmaceuticals, Ltd. · 2013 · Recalled

Showing 5 of 33 descendants. See all descendants

Descendants cleared per year

2008: 12010: 12012: 12013: 22014: 22016: 12018: 82019: 22020: 52023: 32024: 22025: 32026: 2
2008high 8 (2018) · low 0 (2009)2026

Most influential descendants

Showing 5 of 33 · See all
  • K073485Vistakon (Narafilcon) a Soft Contact LensJohnson & Johnson Vision Care, Inc. · 2008 · cites it directly30descendants
  • K100349Vistakon (Narafilcon B) Contact Lens Visibility Tinted with UV BlockerJohnson & Johnson Vision Care, Inc. · 2010 · 2 generations on13descendants
  • K113168Dailies Total Dalies Total for Astigmatism Dailies Total Multifocal Dailies Total…Ciba Vision Corporation · 2012 · 3 generations on12descendants
  • K160344Si-Hy (olifilcon B) sperical silicone hydrogel soft contact lens, Si-Hy (olifilcon B)…Visco Vision, Inc. · 2016 · 2 generations on8descendants
  • K130331Sauflon Clariti 1 Day (Somofilcon a) Soft (Hydrophilic) Daily Disposable Contact Lens…Sauflon Pharmaceuticals, Ltd. · 2013 · 2 generations on6descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K032340Vistakon (Galyfilcon a) Soft Contact LensJohnson & Johnson Vision Care, Inc.2003—
+1K073485Vistakon (Narafilcon) a Soft Contact LensJohnson & Johnson Vision Care, Inc.2008—
+2K100349Vistakon (Narafilcon B) Contact Lens Visibility Tinted with UV BlockerJohnson & Johnson Vision Care, Inc.2010—
+3K113168Dailies Total Dalies Total for Astigmatism Dailies Total Multifocal Dailies…Ciba Vision Corporation2012—
+2K160344Si-Hy (olifilcon B) sperical silicone hydrogel soft contact lens, Si-Hy…Visco Vision, Inc.2016—
+2K130331Sauflon Clariti 1 Day (Somofilcon a) Soft (Hydrophilic) Daily Disposable…Sauflon Pharmaceuticals, Ltd.201317

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
201010
201210
201320
201420
201610
201880
201920
202050
202330
202420
202530
202620
FIG. 1 — Lineage of K032340, 2003–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LPL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LPL device

  1. #1 K243868 Pegavision (Toufilcon B) Daily Disposable Soft…score 16.8 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Focus NIGHT AND DAY (lotrafilcon A)
Named without a submission number
—

What descends from it? (33)

See all 33

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K073485Vistakon (Narafilcon) a Soft Contact LensJohnson & Johnson Vision Care, Inc.200830
K130342Sauflon Clariti (Somofilcon a) Soft (Hydrophilic) Contact Lens with UV BlockerSauflon Pharmaceuticals, Ltd.20132

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 19, 2017Class IIZ-1210-2018Packaging process controlSome contact lenses were associated with complaints of a foreign matter caught between the blister package and foil.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K073485 (Johnson & Johnson Vision Care, Inc., 2008) has gone furthest, with 30 descendants of its own.

How does its category compare?

All LPL devices

LPL Lenses, Soft Contact, Daily Wear: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LPL

12in 2025

2007: 32008: 102009: 62010: 92011: 122012: 122013: 172014: 152015: 122016: 212017: 92018: 212019: 112020: 102021: 82022: 92023: 102024: 122025: 122026 (partial year): 10
2007high 21 (2016) · low 3 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LPL

202in 2025

2007: 281 days median2008: 104 days median2009: 260 days median2010: 244 days median2011: 170 days median2012: 131 days median2013: 135 days median2014: 102 days median2015: 120 days median2016: 112 days median2017: 98 days median2018: 56 days median2019: 115 days median2020: 158 days median2021: 88 days median2022: 212 days median2023: 167 days median2024: 128 days median2025: 202 days median2026 (partial year): 90 days median
2007high 281 (2007) · low 56 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LPL

1in 2025

2007: 12009: 12011: 52012: 12014: 12015: 12017: 112020: 12022: 12025: 12026 (partial year): 1
2007high 11 (2017) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LPL

216in 2025

2007: 2802008: 2142009: 1372010: 2222011: 3772012: 2502013: 1512014: 1792015: 1612016: 1932017: 2802018: 2572019: 2052020: 1172021: 1102022: 1262023: 1782024: 2972025: 216
2007high 377 (2011) · low 110 (2021)2025

MAUDE reports naming product code LPL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200732811280
2008101040214
200962601137
201092440222
2011121705377
2012121311250
2013171350151
2014151021179
2015121201161
2016211120193
201799811280
201821560257
2019111150205
2020101581117
20218880110
202292121126
2023101670178
2024121280297
2025122021216
202610901—

What is it indicated for?

The VISTAKON®(galyfilcon A) Contact Lens is indicated for daily wear for the correction of refractive ametropia (myopia and hyperopia) in aphakic or not-aphakic persons with non-diseased eyes who may have 1.OOD or less of astigmatism. The VISTAKON®(galyfilcon A) Multifocal Contact Lens is indicated for daily wear for the correction of distance and near vision in presbyopic, aphakic or not-aphakic persons with non-diseased eyes who may have 0.75 D of…

Read the full statement (211 words)

The VISTAKON®(galyfilcon A) Contact Lens is indicated for daily wear for the correction of refractive ametropia (myopia and hyperopia) in aphakic or not-aphakic persons with non-diseased eyes who may have 1.OOD or less of astigmatism.

The VISTAKON®(galyfilcon A) Multifocal Contact Lens is indicated for daily wear for the correction of distance and near vision in presbyopic, aphakic or not-aphakic persons with non-diseased eyes who may have 0.75 D of astigmatism or less.

The VISTAKON®(galyfilcon A) Toric Contact Lens is indicated for daily wear for the correction of visual acuity in aphakic or not-aphakic persons with non-diseased eyes that are hyperopic or myopic and may have 10.00 D of astigmatism or less.

The VISTAKON* (galyfilcon A) Toric-Multifocal Contact Lens is indicated for daily wear for the correction of distance and near vision in presbyopic aphakic or not-aphakic persons with non-diseased who may have 10.00 D of astigmatism or less.

VISTAKON®(galyfilcon A) UV Blocking Contact Lenses help protect against transmission of harmful W radiation to the cornea and into the eye.

Eye Care Practitioners may prescribe the lenses either for single-use disposable wear or frequenuplanned replacement wear with cleaning, disinfection and scheduled replacement (see “Wearing Schedule”). When prescribed for frequenuplanned replacement wear, the lenses may be disinfected using a chemical disinfection system only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K032340: Vistakon (Galyfilcon a) Soft Contact Lens.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K032340

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026